iodofiltic acid has been researched along with Renal Insufficiency, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, T; Iwamoto, N; Kobayashi, H; Nishida, M; Nishimura, M; Okamoto, Y; Okino, K; Ono, T; Sato, N; Takahashi, H; Tokoro, T; Yamazaki, S | 1 |
| Hashimoto, T; Kobayashi, H; Nishida, M; Nishimura, M; Okamoto, Y; Ono, T; Sato, N; Takatani, T; Yamazaki, S | 1 |
2 trial(s) available for iodofiltic acid and Renal Insufficiency, Chronic
| Article | Year |
|---|---|
Clinical potential of oral nicorandil to improve myocardial fatty acid metabolism after percutaneous coronary intervention in hemodialysis patients.
Topics: Aged; Coronary Artery Disease; Death, Sudden, Cardiac; Fatty Acids; Female; Follow-Up Studies; Heart; Heart Failure; Humans; Iodine Radioisotopes; Iodobenzenes; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Myocardium; Nicorandil; Percutaneous Coronary Intervention; Renal Dialysis; Renal Insufficiency, Chronic; Survival Rate; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2014 |
Improvement of myocardial fatty acid metabolism by oral nicorandil in hemodialysis patients without coronary artery disease.
Topics: Administration, Oral; Aged; Cardiovascular Diseases; Coronary Artery Disease; Disease-Free Survival; Fatty Acids; Female; Heart; Humans; Iodobenzenes; Male; Middle Aged; Myocardium; Nicorandil; Renal Dialysis; Renal Insufficiency, Chronic; Serum Albumin; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2015 |